Direct Mechanical Thrombectomy Versus Bridging Therapy
- Conditions
- ThrombectomyLarge-Artery Atherosclerosis (Embolus/Thrombosis)Ischemic Stroke
- Interventions
- Device: Trevo and or Merci devices for stent retreivalDevice: Penumbra system for stent aspiration
- Registration Number
- NCT05155540
- Lead Sponsor
- Alexandria University
- Brief Summary
This study compares the efficacy and safety of direct mechanical thrombectomy versus bridging therapy in patients with anterior circulation large vessel occlusion in a cohort of patients treated at the stroke unit of a single centre at Alexandria University in Egypt.
- Detailed Description
This study compares the efficacy and safety of direct mechanical thrombectomy versus bridging therapy in patients with anterior circulation large vessel occlusion in a cohort of patients treated at the stroke unit of a single centre at Alexandria University in Egypt. In the first arm, 17 patients were recruited and underwent direct mechanical thrombectomy without receiving recombinant tissue plasminogen activator. In the bridging therapy arm, 34 patients received first tissue plasminogen activator then underwent direct mechanical thrombectomy. The efficacy was evaluated by the NIHSS improvement 24 hours following stroke onset and the modified Rankin scale 3 months following stroke. Safety was assessed by the procedural complications rate especially the hemorhagic transformation.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 51
- Patients with anterior ischemic stroke due to large vessel occlusion.
- A previous autonomous modified Rankin Scale (mRS) of less than 2.
- A National Institutes of Health Stroke Scale (NIHSS)≥4
- A groin puncture within 4.5 hours of the neurological deficit onset.
- Imaging documentation of intracranial haemorrhage
- A premorbid mRS score of 2 or more
- Absence of diffusion perfusion mismatch in CT perfusion.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Direct mechanical thrombectomy Trevo and or Merci devices for stent retreival Direct mechanical thrombectomy performed within 4.5 of stroke onset without giving intravenous recombinant tissue plasminogen activator. Direct mechanical thrombectomy Penumbra system for stent aspiration Direct mechanical thrombectomy performed within 4.5 of stroke onset without giving intravenous recombinant tissue plasminogen activator. Bridging therapy Trevo and or Merci devices for stent retreival Mechanical thrombectomy performed within 4.5 of stroke onset after giving intravenous recombinant tissue plasminogen activator at a dose of 0.9 mg/Kg Bridging therapy Penumbra system for stent aspiration Mechanical thrombectomy performed within 4.5 of stroke onset after giving intravenous recombinant tissue plasminogen activator at a dose of 0.9 mg/Kg Bridging therapy recombinant tissue plasminogen activator Mechanical thrombectomy performed within 4.5 of stroke onset after giving intravenous recombinant tissue plasminogen activator at a dose of 0.9 mg/Kg
- Primary Outcome Measures
Name Time Method Complication rate within one week postoperatively The rate and type of complications occuring postoperatively
Modified Rankin Scale score 3 months A measurement of functional independence following ischemic stroke
- Secondary Outcome Measures
Name Time Method The National Institutes of Health Stroke Scale (NIHSS) score at 24 hours postoperatively A validated scale for assessment of neurological dysfunction associated with stroke
Trial Locations
- Locations (1)
Alexandria University Faculty of Medicine
🇪🇬Alexandria, Egypt